Contribution of SDF-1α/CXCR4 signaling to brain development and glioma progression

NeuroSignals

Volumn 21, Issue 3-4, 2013, Pages 240-258

  Jiang, Zheng ^a   Zhou, Wei ^b   Guan, Shanghui ^b   Wang, Jianbo ^b   Liang, Yemin ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Brain; Cancer; Chemokines; Neuropathology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; CLOTRIMAZOLE; DOPAMINE; FRACTALKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN DERIVATIVE; MIRTAZAPINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLERIXAFOR; PROSTAGLANDIN; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; 4 AMINOBUTYRIC ACID RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CANNABINOID; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR7; COMPLEMENT COMPONENT C3A; CYCLIC AMP; DIPEPTIDYL PEPTIDASE IV; GLUTAMIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; OPIATE; VASCULOTROPIN;

ANGIOGENESIS; BRAIN DEVELOPMENT; BRAIN FUNCTION; CANCER GROWTH; CANCER RESISTANCE; CELL SURVIVAL; CHEMORESISTANCE; GLIA CELL; GLIOMA; HISTOPATHOLOGY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMAGING SYSTEM; METASTASIS; METHYLATION; MYELOMA; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHODGKIN LYMPHOMA; NONHUMAN; ONCOLOGICAL PARAMETERS; ONCOLYTIC VIROTHERAPY; POSITIVE FEEDBACK; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVIEW; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; ALZHEIMER DISEASE; AUTOCRINE EFFECT; AUTONOMIC DYSFUNCTION; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISTANT METASTASIS; DNA METHYLATION; ELECTRIC ACTIVITY; GLIOMA CELL; INTERNEURON; MOLECULAR IMAGING; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; PARKINSON DISEASE; PREVALENCE; PROFESSIONAL KNOWLEDGE; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPTIC TRANSMISSION;

BRAIN; BRAIN NEOPLASMS; CHEMOKINE CXCL12; DISEASE PROGRESSION; GLIOMA; HUMANS;

EID: 84878015545     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000339091     Document Type: Review

References (203)

1. Gangadhar T, Nandi S, Salgia R: The role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther 2010; 9: 409-416.
2. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
3. Scala S, Giuliano P, Ascierto PA, Ierano C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caraco C, Nicoletti G, Satriano RA, Castello G: Human melanoma metastases express functional CXCR4. Clin Cancer Res 2006; 12: 2427-2433.
4. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB: Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 2006; 25: 4986- 4997.
5. Otsuka S, Bebb G: The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer. J Thorac Oncol 2008; 3: 1379-1383.
6. Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, Dwinell MB: Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc Natl Acad Sci USA 2011; 108: 17655-17660.
7. Janowski M: Functional diversity of SDF-1 splicing variants. Cell Adh Migr 2009; 3: 243- 249.
8. Banisadr G, Skrzydelski D, Kitabgi P, Rostene W, Parsadaniantz SM: Highly regionalized distribution of stromal cell-derived factor- 1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci 2003; 18: 1593-1606.
9. Banisadr G, Dicou E, Berbar T, Rostene W, Lombet A, Haour F: Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J Neuroimmunol 2000; 110: 151-160.
10. Banisadr G, Fontanges P, Haour F, Kitabgi P, Rostene W, Mélik Parsadaniantz S: Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci 2002; 16: 1661-1671.
11. Trecki J, Brailoiu GC, Unterwald EM: Localization of CXCR4 in the forebrain of the adult rat. Brain Res 2010; 1315: 53-62.
12. Westmoreland SV, Alvarez X, deBakker C, Aye P, Wilson ML, Williams KC, Lackner AA: Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J Neuroimmunol 2002; 122: 146-158.
13. van der Meer P, Ulrich AM, Gon?alez- Scarano F, Lavi E: Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 2000; 69: 192-201.
14. Köller H, Schaal H, Rosenbaum C, Czardybon M, Von Giesen HJ, Müller HW, Arendt G: Functional CXCR4 receptor development parallels sensitivity to HIV-1 gp120 in cultured rat astroglial cells but not in cultured rat cortical neurons. J Neurovirol 2002; 8: 411-419.
15. Van Der Meer P, Goldberg SH, Fung KM, Sharer LR, González-Scarano F, Lavi E: Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol 2001; 60: 25-32.
16. Futahashi Y, Komano J, Urano E, Aoki T, Hamatake M, Miyauchi K, Yoshida T, Koyanagi Y, Matsuda Z, Yamamoto N: Separate elements are required for ligand-dependent and -independent internalization of metastatic potentiator CXCR4. Cancer Sci 2007; 98: 373- 379.
17. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005,21; 280: 35760-35766.
18. Schönemeier B, Kolodziej A, Schulz S, Jacobs S, Hoellt V, Stumm R: Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J Comp Neurol 2008; 510: 207-220.
19. Zhou W, Jiang Z, Song X, Liu Y, Wen P, Guo Y, Xu F, Kong L, Zhang P, Han A, Yu J: Promoter hypermethylation-mediated downregulation of CXCL12 in human astrocytoma. J Neurosci Res 2008; 86: 3002-3010.
20. Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP: CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 1998; 69: 99-104.
21. Rempel SA, Dudas S, Ge S, Gutiérrez JA: Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6: 102-111.
22. Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, Price RR, Abel TW, Mapara KY, Thompson RC: CXCR4 expression is elevated in glioblastoma mul tiforme and correlates with an increase in intensity and extent of peri tumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 2008; 63: 560-569; discussion 569- 570.
23. Yang SX, Chen JH, Jiang XF, Wang QL, Chen ZQ, Zhao W, Feng YH, Xin R, Shi JQ, Bian XW: Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Commun 2005; 335: 523-528.
24. Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB: Widespread CXCR4 activation in astrocytomas revealed by phospho- CXCR4-specific antibodies. Cancer Res 2005; 65: 11392-11399.
25. Bian XW, Yang SX, Chen JH, Ping YF, Zhou XD, Wang QL, Jiang XF, Gong W, Xiao HL, Du LL, Chen ZQ, Zhao W, Shi JQ, Wang JM: Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery 2007; 61: 570-578; discussion 578-579.
26. Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P, Ravetti JL, Zona G, Spaziante R, Florio T, Schettini G: Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann NY Acad Sci 2002; 973: 60-69.
27. Komatani H, Sugita Y, Arakawa F, Ohshima K, Shigemori M: Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 2009; 34: 665-672.
28. Salmaggi A, Gelati M, Pollo B, Marras C, Silvani A, Balestrini MR, Eoli M, Fariselli L, Broggi G, Boiardi A: CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. J Neurooncol 2005; 74: 287-293.
29. Maderna E, Salmaggi A, Calatozzolo C, Limido L, Pollo B: Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information. Cancer Biol Ther 2007; 6: 1018-1024.
30. Calatozzolo C, Maderna E, Pollo B, Gelati M, Marras C, Silvani A, Croci D, Boiardi A, Salmaggi A: Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. Cancer Biol Ther 2006; 5: 827-832.
31. McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS: CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 8053-8064.
32. Kanda S, Mochizuki Y, Kanetake H: Stromal cell-derived factor-1alpha induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase. J Biol Chem 2003; 278: 257-262.
33. Bajetto A, Barbieri F, Dorcaratto A, Barbero S, Daga A, Porcile C, Ravetti JL, Zona G, Spaziante R, Corte G, Schettini G, Florio T: Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 2006; 49: 423-432.
34. Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW: Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am J Pathol 2008; 173: 545-560.
35. Zhou W, Jiang Z, Liu N, Xu F, Wen P, Liu Y, Zhong W, Song X, Chang X, Zhang X, Wei G, Yu J: Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas. J Cancer Res Clin Oncol 2009; 135: 91-102.
36. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
37. Wendt MK, Cooper AN, Dwinell MB: Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008; 27: 1461-1471.
38. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G: Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003; 63: 1969-1974.
39. Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N: Stromal cell-derived factor-1/chemokine (CX- C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol Cancer Res 2007; 5: 21-33.
40. Gonzalez-Perez O, Jauregui-Huerta F, Galvez- Contreras AY: Immune system modulates the function of adult neural stem cells. Curr Immunol Rev 2010; 6: 167-173.
41. Pritchett J, Wright C, Zeef L, Nadarajah B: Stromal derived factor-1 exerts differential regulation on distinct cortical cell populations in vitro. BMC Dev Biol 2007; 7: 31.
42. Tissir F, Wang CE, Goffinet AM: Expression of the chemokine receptor Cxcr4 mRNA during mouse brain development. Brain Res Dev Brain Res 2004; 149: 63-71.
43. van der Meulen AA, Biber K, Lukovac S, Balasubramaniyan V, den Dunnen WF, Boddeke HW, Mooij JJ: The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour. Neuropathol Appl Neurobiol 2009; 35: 579-591.
44. Peng H, Huang Y, Rose J, Erichsen D, Herek S, Fujii N, Tamamura H, Zheng J: Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J Neurosci Res 2004; 76: 35-50.
45. Krathwohl MD, Kaiser JL: Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 2004; 22: 109-118.
46. Li M, Chang CJ, Lathia JD, Wang L, Pacenta HL, Cotleur A, Ransohoff RM: Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells. Glia 2011; 59: 108-118.
47. Li M, Ransohoff RM: Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 2008; 84: 116-131.
48. Borrell V, Marín O: Meninges control tangential migration of hem-derived Cajal- Retzius cells via CXCL12/CXCR4 signaling. Nat Neurosci 2006; 9: 1284-1293.
49. Paredes MF, Li G, Berger O, Baraban SC, Pleasure SJ: Stromal-derived factor-1 (CXCL12) regulates laminar position of Cajal-Retzius cells in normal and dysplastic brains. J Neurosci 2006; 26: 9404-9412.
50. Stumm RK, Zhou C, Ara T, Lazarini F, Dubois- Dalcq M, Nagasawa T, Höllt V, Schulz S: CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 2003; 23: 5123-5130.
51. Marchionni I, Takács VT, Nunzi MG, Mugnaini E, Miller RJ, Maccaferri G: Distinctive properties of CXC chemokine receptor 4-expressing Cajal-Retzius cells versus GABAergic interneurons of the postnatal hippocampus. J Physiol 2010; 588: 2859-2878.
52. Zhu Y, Yu T, Zhang XC, Nagasawa T, Wu JY, Rao Y: Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci 2002; 5: 719-720.
53. Yu T, Huang H, Li HF: Stromal cell-derived factor-1 promotes migration of cells from the upper rhombic lip in cerebellar development. J Neurosci Res 2010; 88: 2775-2786.
54. Klein RS, Rubin JB, Gibson HD, DeHaan EN, Alvarez-Hernandez X, Segal RA, Luster AD: SDF-1 alpha induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 2001; 128: 1971-1981.
55. Bagri A, Gurney T, He X, Zou YR, Littman DR, Tessier-Lavigne M, Pleasure SJ: The chemokine SDF1 regulates migration of dentate granule cells. Development 2002; 129: 4249- 4260.
56. Li G, Kataoka H, Coughlin SR, Pleasure SJ: Identification of a transient subpial neurogenic zone in the developing dentate gyrus and its regulation by Cxcl12 and reelin signaling. Development 2009; 136: 327-335.
57. Lu M, Grove EA, Miller RJ: Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 2002; 99: 7090-7095.
58. Ohshima Y, Kubo T, Koyama R, Ueno M, Nakagawa M, Yamashita T: Regulation of axonal elongation and pathfinding from the entorhinal cortex to the dentate gyrus in the hippocampus by the chemokine stromal cell-derived factor 1 alpha. J Neurosci 2008; 28: 8344-8353.
59. Berger O, Li G, Han SM, Paredes M, Pleasure SJ: Expression of SDF-1 and CXCR4 during reorganization of the postnatal dentate gyrus. Dev Neurosci 2007; 29: 48-58.
60. Bhattacharyya BJ, Banisadr G, Jung H, Ren D, Cronshaw DG, Zou Y, Miller RJ: The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J Neurosci 2008; 28: 6720-6730.
61. López-Bendito G, Sánchez-Alcaniz JA, Pla R, Borrell V, Picó E, Valdeolmillos M, Marín O: Chemokine signaling controls intracortical migration and final distribution of GABAergic interneurons. J Neurosci 2008; 28: 1613- 1624.
62. Anderson SA, Kaznowski CE, Horn C, Rubenstein JL, McConnell SK: Distinct origins of neocortical projection neurons and interneurons in vivo. Cereb Cortex 2002; 12: 702- 709.
63. Letinic K, Zoncu R, Rakic P: Origin of GABAergic neurons in the human neocortex. Nature 2002; 417: 645-649.
64. Tiveron MC, Rossel M, Moepps B, Zhang YL, Seidenfaden R, Favor J, König N, Cremer H: Molecular interaction between projection neuron precursors and invading interneurons via stromal-derived factor 1 (CXCL12)/ CXCR4 signaling in the cortical subventricular zone/intermediate zone. J Neurosci 2006; 26: 13273-13278.
65. Khan MZ, Brandimarti R, Musser BJ, Resue DM, Fatatis A, Meucci O: The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons. J Neurovirol 2003; 9: 300-314.
66. Tanaka DH, Mikami S, Nagasawa T, Miyazaki J, Nakajima K, Murakami F: CXCR4 is required for proper regional and laminar distribution of cortical somatostatin-, calretinin-, and neuropeptide Y-expressing GABAergic interneurons. Cereb Cortex 2010; 20: 2810-2817.
67. Liodis P, Denaxa M, Grigoriou M, Akufo- Addo C, Yanagawa Y, Pachnis V: Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. J Neurosci 2007; 27: 3078-3089.
68. Li G, Adesnik H, Li J, Long J, Nicoll RA, Rubenstein JL, Pleasure SJ: Regional distribution of cortical interneurons and development of inhibitory tone are regulated by Cxcl12/Cxcr4 signaling. J Neurosci 2008; 28: 1085-1098.
69. Stumm R, Kolodziej A, Schulz S, Kohtz JD, Höllt V: Patterns of SDF-1alpha and SDF- 1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon. J Comp Neurol 2007; 502: 382-399.
70. Liapi A, Pritchett J, Jones O, Fujii N, Parnavelas JG, Nadarajah B: Stromal-derived factor signalling regulates radial and tangential migration in the developing cerebral cortex. Dev Neurosci 2008; 30: 117-131.
71. Luo Y, Lathia J, Mughal M, Mattson MP: SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J Biol Chem 2008; 283: 24789-24800.
72. Arakawa Y, Bito H, Furuyashiki T, Tsuji T, Takemoto-Kimura S, Kimura K, Nozaki K, Hashimoto N, Narumiya S: Control of axon elongation via an SDF-1alpha/Rho/mDia pathway in cultured cerebellar granule neurons. J Cell Biol 2003; 161: 381-391.
73. Pujol F, Kitabgi P, Boudin H: The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci 2005; 118: 1071-1080.
74. Xiang Y, Li Y, Zhang Z, Cui K, Wang S, Yuan XB, Wu CP, Poo MM, Duan S: Nerve growth cone guidance mediated by G protein-coupled receptors. Nat Neurosci 2002; 5: 843-848.
75. Baudouin SJ, Pujol F, Nicot A, Kitabgi P, Boudin H: Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation. Mol Cell Neurosci 2006; 33: 160-169.
76. Miyasaka N, Knaut H, Yoshihara Y: Cxcl12/ Cxcr4 chemokine signaling is required for placode assembly and sensory axon pathfinding in the zebrafish olfactory system. Development 2007; 134: 2459-2468.
77. Limatola C, Giovannelli A, Maggi L, Ragozzino D, Castellani L, Ciotti MT, Vacca F, Mercanti D, Santoni A, Eusebi F: SDF-1alpha- mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci 2000; 12: 2497-2504.
78. Ragozzino D, Renzi M, Giovannelli A, Eusebi F: Stimulation of chemokine CXC receptor induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J Neuroimmunol 2002; 127: 30-36.
79. Guyon A, Rovere C, Cervantes A, Allaeys I, Nahon JL: Stromal cell-derived factor-1alpha directly modulates voltage-dependent currents of the action potential in mammalian neuronal cells. J Neurochem 2005; 93: 963-973.
80. Liu Z, Geng L, Li R, He X, Zheng JQ, Xie Z: Frequency modulation of synchronized Ca2+ spikes in cultured hippocampal networks through G-protein-coupled receptors. J Neurosci 2003; 23: 4156-4163.
81. Mohajerani MH, Cherubini E: Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus. Crit Rev Neurobiol 2006; 18: 13-23.
82. Kasiyanov A, Fujii N, Tamamura H, Xiong H: Modulation of network-driven, GABAmediated giant depolarizing potentials by SDF-1alpha in the developing hippocampus. Dev Neurosci 2008; 30: 285-292.
83. Kolodziej A, Schulz S, Guyon A, Wu DF, Pfeiffer M, Odemis V, Höllt V, Stumm R: Tonic activation of CXC chemokine receptor in immature granule cells supports neurogenesis in the adult dentate gyrus. J Neurosci 2008; 28: 4488-4500.
84. Zhu Y, Matsumoto T, Mikami S, Nagasawa T, Murakami F: SDF1/CXCR4 signalling regulates two distinct processes of precerebellar neuronal migration and its depletion leads to abnormal pontine nuclei formation. Development 2009; 136: 1919-1928.
85. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M: A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 2005; 50: 258-269.
86. Kadi L, Selvaraju R, de Lys P, Proudfoot AE, Wells TN, Boschert U: Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol 2006; 174: 133-146.
87. Patel JR, McCandless EE, Dorsey D, Klein RS: CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 2010; 107: 11062-11067.
88. Cali C, Bezzi P: CXCR4-mediated glutamate exocytosis from astrocytes. J Neuroimmunol 2010; 224: 13-21.
89. Prebil M, Jensen J, Zorec R, Kreft M: Astrocytes and energy metabolism. Arch Physiol Biochem 2011; 117: 64-69.
90. Barbieri F, Bajetto A, Porcile C, Pattarozzi A, Schettini G, Florio T: Role of stromal cellderived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. J Mol Endocrinol 2007; 38: 383-389.
91. Florio T, Casagrande S, Diana F, Bajetto A, Porcile C, Zona G, Thellung S, Arena S, Pattarozzi A, Corsaro A, Spaziante R, Robello M, Schettini G: Chemokine stromal cell-derived factor 1alpha induces proliferation and growth hormone release in GH4C1 rat pituitary adenoma cell line through multiple intracellular signals. Mol Pharmacol 2006; 69: 539-546.
92. Lee Y, Kim JM, Lee EJ: Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation. J Endocrinol 2008; 199: 191-199.
93. Palevitch O, Abraham E, Borodovsky N, Levkowitz G, Zohar Y, Gothilf Y: Cxcl12a- Cxcr4b signaling is important for proper development of the forebrain GnRH system in zebrafish. Gen Comp Endocrinol 2010; 165: 262-268.
94. Schwarting GA, Henion TR, Nugent JD, Caplan B, Tobet S: Stromal cell-derived factor- (chemokine C-X-C motif ligand 12) and chemokine C-X-C motif receptor 4 are required for migration of gonadotropin-releasing hormone neurons to the forebrain. J Neurosci 2006; 26: 6834-6840.
95. Toba Y, Tiong JD, Ma Q, Wray S: CXCR4/ SDF-1 system modulates development of GnRH-1 neurons and the olfactory system. Dev Neurobiol 2008; 68: 487-503.
96. Guyon A, Banisadr G, Rovere C, Cervantes A, Kitabgi P, Melik-Parsadaniantz S, Nahon JL: Complex effects of stromal cell-derived factor-1 alpha on melanin-concentrating hormone neuron excitability. Eur J Neurosci 2005; 21: 701-710.
97. Callewaere C, Banisadr G, Desarménien MG, Mechighel P, Kitabgi P, Rostene WH, Mélik Parsadaniantz S: The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc Natl Acad Sci USA 2006; 103: 8221-8226.
98. Callewaere C, Fernette B, Raison D, Mechighel P, Burlet A, Calas A, Kitabgi P, Parsadaniantz SM, Rostene W: Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cellderived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats. Endocrinology 2008; 149: 310-319.
99. Shimoji M, Pagan F, Healton EB, Mocchetti I: CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson's disease. Neurotox Res 2009; 16: 318-328.
100. Skrzydelski D, Guyon A, Daugé V, Rovere C, Apartis E, Kitabgi P, Nahon JL, Rostene W, Parsadaniantz SM: The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J Neurochem 2007; 102: 1175-1183.
101. Guyon A, Skrzydelski D, Rovere C, Apartis E, Rostene W, Kitabgi P, Mélik Parsadaniantz S, Nahon JL: Stromal-cell-derived factor 1alpha /CXCL12 modulates highthreshold calcium currents in rat substantia nigra. Eur J Neurosci 2008; 28: 862-870.
102. Guyon A, Skrzydelsi D, Rovere C, Rostene W, Parsadaniantz SM, Nahon JL: Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J Neurochem 2006; 96: 1540-1550.
103. Wang F, Yasuhara T, Shingo T, Kameda M, Tajiri N, Yuan WJ, Kondo A, Kadota T, Baba T, Tayra JT, Kikuchi Y, Miyoshi Y, Date I: Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci 2010; 11: 52.
104. Heinisch S, Palma J, Kirby LG: Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey. Brain Behav Immun 2011; 25: 360-372.
105. Pello OM, Martínez-Munoz L, Parrillas V, Serrano A, Rodríguez-Frade JM, Toro MJ, Lucas P, Monterrubio M, Martínez-A C, Mellado M: Ligand stabilization of CXCR4/ delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur J Immunol 2008; 38: 537-549.
106. Burbassi S, Aloyo VJ, Simansky KJ, Meucci O: GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4. J Neuroimmune Pharmacol 2008; 3: 26-34.
107. Finley MJ, Chen X, Bardi G, Davey P, Geller EB, Zhang L, Adler MW, Rogers TJ: Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor. J Neuroimmunol 2008; 197: 114-123.
108. Benamar K, Palma J, Cowan A, Geller EB, Adler MW: Analgesic efficacy of buprenorphine in the presence of high levels of SDF- 1-/CXCL12 in the brain. Drug Alcohol Depend 2011; 114: 246-248.
109. Szabo I, Chen XH, Xin L, Adler MW, Howard OM, Oppenheim JJ, Rogers TJ: Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci USA 2002; 99: 10276-10281.
110. Burbassi S, Sengupta R, Meucci O: Alterations of CXCR4 function in -opioid receptor- deficient glia. Eur J Neurosci 2010; 32: 1278-1288.
111. Adler MW, Rogers TJ: Are chemokines the third major system in the brain? J Leukoc Biol 2005; 78: 1204-1209.
112. Benamar K, Geller EB, Adler MW: First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain. J Pharmacol Exp Ther 2008; 325: 641-645.
113. Benamar K, Yondorf M, Geller EB, Eisenstein TK, Adler MW: Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain. Br J Pharmacol 2009; 157: 1225-1231.
114. Heinisch S, Kirby LG: SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuropharmacology 2010; 58: 501-514.
115. Hermann GE, Van Meter MJ, Rogers RC: CXCR4 receptors in the dorsal medulla: implications for autonomic dysfunction. Eur J Neurosci 2008; 27: 855-864.
116. Lieberam I, Agalliu D, Nagasawa T, Ericson J, Jessell TM: A Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons. Neuron 2005; 47: 667-679.
117. Odemis V, Lamp E, Pezeshki G, Moepps B, Schilling K, Gierschik P, Littman DR, Engele J: Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis. Mol Cell Neurosci 2005; 30: 494-505.
118. Parachikova A, Cotman CW: Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol Dis 2007; 28: 143-153.
119. Parachikova A, Nichol KE, Cotman CW: Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis 2008; 30: 121-129.
120. Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Höllt V, Schulz S: A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865-5878.
121. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, Maeda M, Fagan SC, Carroll JE, Conway SJ: SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 2004; 63: 84-96.
122. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, Zhang L, Wang Y, Zhang C, Chopp M: Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 2006; 26: 125-134.
123. Chang YC, Shyu WC, Lin SZ, Li H: Regenerative therapy for stroke. Cell Transplant 2007; 16: 171-181.
124. Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW: Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 2006; 86: 1221-1232.
125. Salcedo R, Oppenheim JJ: Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 2003; 10: 359-370.
126. Mirshahi F, Pourtau J, Li H, Muraine M, Trochon V, Legrand E, Vannier J, Soria J, Vasse M, Soria C: SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res 2000; 99: 587-594.
127. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ: Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000; 14: 2055-2064.
128. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ: Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal- derived factor-1alpha. Am J Pathol 1999; 154: 1125-1135.
129. Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T, Chopp M: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett 2006; 236: 39-45.
130. Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J, Semenza GL: Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-offunction induces expression of a ligand and its receptor. Cancer Res 2005; 65: 6178- 6188.
131. Tabatabai G, Frank B, Möhle R, Weller M, Wick W: Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. Brain 2006; 129: 2426-2435.
132. Soeda A, Park M, Lee D, Mintz A, Androutsellis- Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009; 28: 3949-3959.
133. Zhao D, Najbauer J, Garcia E, Metz MZ, Gutova M, Glackin CA, Kim SU, Aboody KS: Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol Cancer Res 2008; 6: 1819-1829.
134. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A: CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001; 4: 702-710.
135. Cali C, Marchaland J, Regazzi R, Bezzi P: SDF 1-alpha (CXCL12) triggers glutamate exocytosis from astrocytes on a millisecond time scale: imaging analysis at the single- vesicle level with TIRF microscopy. J Neuroimmunol 2008; 198: 82-91.
136. Oh JW, Drabik K, Kutsch O, Choi C, Tousson A, Benveniste EN: CXC chemokine receptor expression and function in human astroglioma cells. J Immunol 2001; 166: 2695-2704.
137. Croitoru-Lamoury J, Guillemin GJ, Boussin FD, Mognetti B, Gigout LI, Chéret A, Vaslin B, Le Grand R, Brew BJ, Dormont D: Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 2003; 41: 354-370.
138. Salcedo R, Oppenheim JJ: Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 2003; 10: 359-370.
139. Egea V, von Baumgarten L, Schichor C, Berninger B, Popp T, Neth P, Goldbrunner R, Kienast Y, Winkler F, Jochum M, Ries C: TNF- - respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Cell Death Differ 2011; 18: 853-863.
140. Han Y, Wang J, He T, Ransohoff RM: TNFalpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res 2001; 888: 1-10.
141. Salmaggi A, Gelati M, Pollo B, Frigerio S, Eoli M, Silvani A, Broggi G, Ciusani E, Croci D, Boiardi A, De Rossi M: CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 2004; 67: 305-317.
142. McCandless EE, Budde M, Lees JR, Dorsey D, Lyng E, Klein RS: IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J Immunol 2009; 183: 613-620.
143. Odemis V, Moepps B, Gierschik P, Engele J: Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation. J Biol Chem 2002; 277: 39801- 39808.
144. Ping YF, Yao XH, Bian XW, Chen JH, Zhang R, Yi L, Zhou ZH: Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis. Zhonghua Bing Li Xue Za Zhi 2007; 36: 179-183.
145. Ping YF, Yao XH, Chen JH, Liu H, Chen DL, Zhou XD, Wang JM, Bian XW: The anticancer compound Nordy inhibits CXCR4- mediated production of IL-8 and VEGF by malignant human glioma cells. J Neurooncol 2007; 84: 21-29.
146. Boos L, Szalai AJ, Barnum SR: C3a expressed in the central nervous system protects against LPS-induced shock. Neurosci Lett 2005; 387: 68-71.
147. Shinjyo N, Stahlberg A, Dragunow M, Pekny M, Pekna M: Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells 2009; 27: 2824-2832.
148. Zhang J, Sarkar S, Yong VW: The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 2005; 26: 2069-2077.
149. Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G: LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways. J Cell Biochem 2008; 103: 245-255.
150. Stremenova J, Krepela E, Mares V, Trim J, Dbaly V, Marek J, Vanickova Z, Lisa V, Yea C, Sedo A: Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int J Oncol 2007; 31: 785-792.
151. Christopherson KW 2nd, Hangoc G, Broxmeyer HE: Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/ stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002; 169: 7000-7008.
152. Busek P, Stremenová J, Krepela E, Sedo A: Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines. Physiol Res 2008; 57: 443-449.
153. Nosheny RL, Ahmed F, Yakovlev A, Meyer EM, Ren K, Tessarollo L, Mocchetti I: Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein in vivo. Eur J Neurosci 2007; 25: 2275-2284.
154. Ahmed F, Tessarollo L, Thiele C, Mocchetti I: Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res 2008; 1227: 1-11.
155. Esencay M, Newcomb EW, Zagzag D: HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration. J Neurooncol 2010; 99: 33-40.
156. Tu H, Zhou Z, Liang Q, Li Z, Li D, Qing J, Wang H, Zhang L: CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion. Onkologie 2009; 32: 331-336.
157. Cook A, Hippensteel R, Shimizu S, Nicolai J, Fatatis A, Meucci O: Interactions between chemokines: regulation of fractalkine/CX- 3CL1 homeostasis by SDF/CXCL12 in cortical neurons. J Biol Chem 2010; 285: 10563- 10571.
158. Alvarez S, Blanco A, Fresno M, Munoz- Fernández MA: Nuclear factor-kappaB activation regulates cyclooxygenase-2 induction in human astrocytes in response to CXCL12: role in neuronal toxicity. J Neurochem 2010; 113: 772-783.
159. Alvarez S, Serramía MJ, Fresno M, Munoz- Fernández MA: HIV-1 envelope glycoprotein induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-kappaB-dependent mechanism. Neuromolecular Med 2007; 9: 179-193.
160. Hagihara K, Zhang EE, Ke YH, Liu G, Liu JJ, Rao Y, Feng GS: Shp2 acts downstream of SDF-1alpha/CXCR4 in guiding granule cell migration during cerebellar development. Dev Biol 2009; 334: 276-284.
161. Oh JW, Olman M, Benveniste EN: CXCL12- mediated induction of plasminogen activator inhibitor-1 expression in human CXCR4 positive astroglioma cells. Biol Pharm Bull 2009; 32: 573-577.
162. Williams CK, Segarra M, Sierra Mde L, Sainson RC, Tosato G, Harris AL: Regulation of CXCR4 by the Notch ligand deltalike in endothelial cells. Cancer Res 2008; 68: 1889-1895.
163. Sciaccaluga M, Fioretti B, Catacuzzeno L, Pagani F, Bertollini C, Rosito M, Catalano M, D'Alessandro G, Santoro A, Cantore G, Ragozzino D, Castigli E, Franciolini F, Limatola C: CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity. Am J Physiol Cell Physiol 2010; 299:C175-C184.
164. Zhou Y, Larsen PH, Hao C, Yong VW: CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277: 49481-49487.
165. Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G: Stromal cellderived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 2001; 77: 1226-1236.
166. Lazarini F, Casanova P, Tham TN, De Clercq E, Arenzana-Seisdedos F, Baleux F, Dubois-Dalcq M: Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur J Neurosci 2000; 12: 117-125.
167. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 2003; 100: 13513-13518.
168. Floridi F, Trettel F, Di Bartolomeo S, Ciotti MT, Limatola C: Signalling pathways involved in the chemotactic activity of CXCL12 in cultured rat cerebellar neurons and CHP100 neuroepithelioma cells. J Neuroimmunol 2003; 135: 38-46.
169. Bonavia R, Bajetto A, Barbero S, Pirani P, Florio T, Schettini G: Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett 2003; 139: 181-189.
170. Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB: Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res 2007; 67: 651-658.
171. Sato N, Matsubayashi H, Fukushima N, Goggins M: The chemokine receptor CXCR4 is regulated byDNA methylation in pancreatic cancer. Cancer Biol Ther 2005; 4: 70-76.
172. Seo J, Kim YO, Jo I: Differential expression of stromal cell-derived factor 1 in human brain microvascular endothelial cells and pericytes involves histone modifications. Biochem Biophys Res Commun 2009; 382: 519-524.
173. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G: Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003; 63: 1969- 1974.
174. do Carmo A, Patricio I, Cruz MT, Carvalheiro H, Oliveira CR, Lopes MC: CXCL12/ CXCR4 promotes motility and proliferation of glioma cells. Cancer Biol Ther 2010; 9: 56-65.
175. Liu XS, Chopp M, Santra M, Hozeska-Solgot A, Zhang RL, Wang L, Teng H, Lu M, Zhang ZG: Functional response to SDF1 alpha through over-expression of CXCR4 on adult subventricular zone progenitor cells. Brain Res 2008; 1226: 18-26.
176. Khan MZ, Brandimarti R, Shimizu S, Nicolai J, Crowe E, Meucci O: The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ 2008; 15: 1663-1672.
177. Rosenkranz K, Kumbruch S, Lebermann K, Marschner K, Jensen A, Dermietzel R, Meier C: The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. J Neurosci Res 2010; 88: 1223- 1233.
178. Ehtesham M, Winston JA, Kabos P, Thompson RC: CXCR4 expression mediates glioma cell invasiveness. Oncogene 2006; 25: 2801-2806.
179. Greenfield JP, Cobb WS, Lyden D: Resisting arrest: a switch from angiogenesis to vasculogenesis in recurrent malignant gliomas. J Clin Invest 2010; 120: 663-667.
180. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM: Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010; 120: 694- 705.
181. Kenig S, Alonso MB, Mueller MM, Lah TT: Glioblastoma and endothelial cells crosstalk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9. Cancer Lett 2010; 289: 53-61.
182. Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA: Tumor stromal-derived factor-recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 2006; 66: 9054-9064.
183. McMillan KM, Ehtesham M, Stevenson CB, Edgeworth ML, Thompson RC, Price RR: T2 detection of tumor invasion within segmented components of glioblastoma multiforme. J Magn Reson Imaging 2009; 29: 251-257.
184. Nimmagadda S, Pullambhatla M, Pomper MG: Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT. J Nucl Med 2009; 50: 1124-1130.
185. Misra P, Lebeche D, Ly H, Schwarzkopf M, Diaz G, Hajjar RJ, Schecter AD, Frangioni JV: Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha. J Nucl Med 2008; 49: 963-969.
186. Park SA, Ryu CH, Kim SM, Lim JY, Park SI, Jeong CH, Jun JA, Oh JH, Park SH, Oh W, Jeun SS: CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. Int J Oncol 2011; 38: 97-103.
187. Tabatabai G, Bähr O, Möhle R, Eyüpoglu IY, Boehmler AM, Wischhusen J, Rieger J, Blümcke I, Weller M, Wick W: Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain 2005; 128: 2200-2211.
188. Redjal N, Chan JA, Segal RA, Kung AL: CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 2006; 12: 6765-6771.
189. Hägerstrand D, Hesselager G, Achterberg S, Wickenberg Bolin U, Kowanetz M, Kastemar M, Heldin CH, Isaksson A, Nistér M, Ostman A: Characterization of an imatinib- sensitive subset of high-grade human glioma cultures. Oncogene 2006; 25: 4913- 4922.
190. Kast RE: Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct. Turk Neurosurg 2010; 20: 425-429.
191. Hatse S, Princen K, De Clercq E, Rosenkilde MM, Schwartz TW, Hernandez-Abad PE, Skerlj RT, Bridger GJ, Schols D: AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Biochem Pharmacol 2005; 70: 752-761.
192. Gravel S, Malouf C, Boulais PE, Berchiche YA, Oishi S, Fujii N, Leduc R, Sinnett D, Heveker N: The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. J Biol Chem 2010; 285: 37939-37943.
193. Cheng Z, Zhou S, Wang X, Xie F, Wu H, Liu G, Wang Q, Chen Y, Hu Y, Lu B, Zhang X: Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1alpha signal. Hybridoma (Larchmt) 2009; 28: 33-41.
194. Kottke T, Hall G, Pulido J, Diaz RM, Thompson J, Chong H, Selby P, Coffey M, Pandha H, Chester J, Melcher A, Harrington K, Vile R: Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. J Clin Invest 2010; 120: 1551- 1560.
195. Müller FJ, Snyder EY, Loring JF: Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 2006; 7: 75-84.
196. Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS: Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther 2009; 16: 262-278.
197. Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, Black KL, Yu JS: Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004; 6: 287-293.
198. Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS: Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 2008; 26: 831-841.
199. Tseng D, Vasquez-Medrano DA, Brown JM: Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas. Br J Cancer 2011; 104: 1805-1809.
200. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK: AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007; 11: 83-95.
201. Wong D, Korz W: Translating an antagonist of chemokine receptor CXCR4: from bench to bedside. Clin Cancer Res 2008; 14: 7975- 7980.
202. Hattermann K, Mentlein R, Held-Feindt J: CXCL12 mediates apoptosis resistance in rat C6 glioma cells. Oncol Rep 2012; 27: 1348-1352.
203. Meincke M, Tiwari S, Hattermann K, Kalthoff H, Mentlein R: Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7. Clin Exp Metastasis 2011; 28: 713-720.